NASDAQ:SLGC

SomaLogic (SLGC) Stock Forecast, Price & News

$2.36

+0.02 (+0.85%)

(As of 09/28/2023 ET)

Compare

Today's Range: $2.27
▼
$2.40
50-Day Range: $1.99
▼
$2.45
52-Week Range: $1.92
▼
$3.79

Volume: 1.24 million shs
Average Volume: 1.02 million shs
Market Capitalization: $443.85 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $5.40

SomaLogic MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.50 Rating Score
Upside/Downside: 128.8% Upside
$5.40 Price Target
Short Interest: Healthy
5.55% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.09
Based on 6 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.66) to ($0.59) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.22 out of 5 stars

Business Services Sector

150th out of 316 stocks

Commercial Physical Research Industry

7th out of 14 stocks

3.3

Analyst's Opinion

Consensus Rating
SomaLogic has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $5.40, SomaLogic has a forecasted upside of 128.8% from its current price of $2.36.
Amount of Analyst Coverage
SomaLogic has only been the subject of 2 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
5.55% of the float of SomaLogic has been sold short.
Short Interest Ratio / Days to Cover
SomaLogic has a short interest ratio ("days to cover") of 9.1.
Change versus previous month
Short interest in SomaLogic has recently decreased by 16.42%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
SomaLogic does not currently pay a dividend.
Dividend Growth
SomaLogic does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for SLGC.

2.3

News and Social Media Coverage

News Sentiment
SomaLogic has a news sentiment score of 0.09. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.63 average news sentiment score of Business Services companies.
News Coverage This Week
MarketBeat has tracked 6 news articles for SomaLogic this week, compared to 1 article on an average week.
Search Interest
Only 1 people have searched for SLGC on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
MarketBeat Follows
2 people have added SomaLogic to their MarketBeat watchlist in the last 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, SomaLogic insiders have not sold or bought any company stock.
Percentage Held by Insiders
14.90% of the stock of SomaLogic is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
66.35% of the stock of SomaLogic is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3

Earnings and Valuation

Earnings Growth
Earnings for SomaLogic are expected to grow in the coming year, from ($0.66) to ($0.59) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of SomaLogic is -3.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of SomaLogic is -3.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
SomaLogic has a P/B Ratio of 0.79. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About SomaLogic (NASDAQ:SLGC) Stock

SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for its cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company's SOMAmers/SomaScan technology enables researchers to analyze various biological samples for protein biomarker signatures, which are utilized in drug discovery and development. Its SomaScan's biomarker discoveries use in diagnostic applications for various diseases, including cardiovascular and metabolic disease, nonalcoholic steatohepatitis, wellness, and others. The company also provides SomaSignal, a laboratory-developed test. It serves pharmaceutical and biotechnology companies, and academic and government research institutions. The company has a collaboration agreement with Illumina Cambridge, Ltd for the development of co-branded NGS-based proteomic distributable kits. The company was founded in 1999 and is headquartered in Boulder, Colorado.

SLGC Price History

30 days | 90 days | 365 days | Advanced Chart

SLGC Stock News Headlines

September 26, 2023 | americanbankingnews.com

SomaLogic (NASDAQ:SLGC) Lowered to "Hold" at Canaccord Genuity Group

September 26, 2023 | americanbankingnews.com

SomaLogic (NASDAQ:SLGC) Receives "Hold" Rating from Canaccord Genuity Group

September 29, 2023 | Behind the Markets (Ad)

Laser breakthrough could send stock soaring 2,467%

Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...

September 19, 2023 | finance.yahoo.com

SomaLogic and Korea’s DNA Link partner to bring the 7,000-plex SomaScan® platform to the fast-growing Asia-Pacific proteomics market

September 12, 2023 | stockhouse.com

SomaLogic researchers identify key proteins to aid in early detection of lung, colon and breast cancer and ovarian tumors

September 5, 2023 | stockhouse.com

SomaLogic expands agreement with Novo Nordisk to 2025

August 18, 2023 | finance.yahoo.com

SomaLogic, Inc. (NASDAQ:SLGC) Just Reported Earnings, And Analysts Cut Their Target Price

August 17, 2023 | finance.yahoo.com

SomaLogic, Inc. (NASDAQ:SLGC) Q2 2023 Earnings Call Transcript

September 29, 2023 | Behind the Markets (Ad)

The single greatest medical breakthrough of all time?

We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.

August 15, 2023 | seekingalpha.com

SLGC Company Calendar

Last Earnings: 8/14/2023
Today: 9/29/2023
Next Earnings (Estimated): 11/13/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Commercial physical research
Sub-Industry: N/A
Sector: Business Services
Current Symbol: NASDAQ:SLGC
CUSIP: N/A
CIK: 1837412
Web: ii.cmlifesciencesspac.com
Phone: 303-625-9000
Fax: N/A
Employees: 451
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $5.40
High Stock Price Forecast: $8.00
Low Stock Price Forecast: $2.50
Forecasted Upside/Downside: +128.8%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.75)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-109,160,000.00
Net Margins: -139.23%
Pretax Margin: -139.94%
Return on Equity: -25.49%
Return on Assets: -22.27%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 16.39
Quick Ratio: 15.91

Sales & Book Value

Annual Sales: $97.67 million
Price / Sales: 4.54
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $3.00 per share
Price / Book: 0.79

Miscellaneous

Outstanding Shares: 188,070,000
Free Float: 160,049,000
Market Cap: $443.85 million
Optionable: Not Optionable
Beta: 1.67

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

Dr. Stephen A. Williams BS (Age 63)
MB, Ph.D., Chief Medical Officer
Comp: $648.03k

Mr. Adam Taich (Age 48)
Interim CEO

Mr. Eliot M. Lurier CPA (Age 65)
CPA, Interim Chief Financial Officer

Mr. Pi Zheng (Age 50)
Interim Chief Accounting Officer

Dr. Jason Cleveland Ph.D.
Chief Technology Officer

Dr. Nebojsa Janjic Ph.D. (Age 62)
Chief Science Officer

Mr. Ruben Gutierrez J.D. (Age 48)
Gen. Counsel

Ms. Alison Marie Roelke (Age 48)
Chief People Officer

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

SLGC Stock - Frequently Asked Questions

Should I buy or sell SomaLogic stock right now?: 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for SomaLogic in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" SLGC shares.
View SLGC analyst ratings or view top-rated stocks.
What is SomaLogic's stock price forecast for 2023?: 4 Wall Street research analysts have issued 1 year price objectives for SomaLogic's shares. Their SLGC share price forecasts range from $2.50 to $8.00. On average, they predict the company's stock price to reach $5.40 in the next twelve months. This suggests a possible upside of 128.8% from the stock's current price.
View analysts price targets for SLGC or view top-rated stocks among Wall Street analysts.
How have SLGC shares performed in 2023?: SomaLogic's stock was trading at $2.51 at the beginning of 2023. Since then, SLGC shares have decreased by 6.0% and is now trading at $2.36.
View the best growth stocks for 2023 here.
Are investors shorting SomaLogic?: SomaLogic saw a decrease in short interest in September. As of September 15th, there was short interest totaling 8,450,000 shares, a decrease of 16.4% from the August 31st total of 10,110,000 shares. Based on an average daily trading volume, of 931,800 shares, the short-interest ratio is presently 9.1 days. Approximately 5.6% of the shares of the company are sold short.
View SomaLogic's Short Interest.
When is SomaLogic's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023.
View our SLGC earnings forecast.
How were SomaLogic's earnings last quarter?: SomaLogic, Inc. (NASDAQ:SLGC) announced its quarterly earnings results on Monday, August, 14th. The company reported ($0.13) earnings per share for the quarter, topping analysts' consensus estimates of ($0.18) by $0.05. The firm earned $20.47 million during the quarter, compared to the consensus estimate of $19.50 million. SomaLogic had a negative trailing twelve-month return on equity of 25.49% and a negative net margin of 139.23%.

What ETF holds SomaLogic's stock ?: ARK Genomic Revolution ETF holds 13,104,112 shares of SLGC stock, representing 1.22% of its portfolio.
What guidance has SomaLogic issued on next quarter's earnings?: SomaLogic issued an update on its FY 2023 earnings guidance on Monday, August, 14th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $80.00 million-$84.00 million, compared to the consensus revenue estimate of $81.62 million.
What is SomaLogic's stock symbol?: SomaLogic trades on the NASDAQ under the ticker symbol "SLGC."
How do I buy shares of SomaLogic?: Shares of SLGC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is SomaLogic's stock price today?: One share of SLGC stock can currently be purchased for approximately $2.36.
How much money does SomaLogic make?: SomaLogic (NASDAQ:SLGC) has a market capitalization of $443.85 million and generates $97.67 million in revenue each year. The company earns $-109,160,000.00 in net income (profit) each year or ($0.75) on an earnings per share basis.
How many employees does SomaLogic have?: The company employs 451 workers across the globe.
How can I contact SomaLogic?: SomaLogic's mailing address is 667 MADISON AVENUE, NEW YORK NY, 10065. The official website for the company is ii.cmlifesciencesspac.com. The company can be reached via phone at 303-625-9000 or via email at investors@somalogic.com.

This page (NASDAQ:SLGC) was last updated on 9/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial